Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.
about
Generation of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cellsOncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF.Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models.Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver.Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
P2860
Q28534405-0EFD60B5-F58B-4CC3-B34E-B5D7702F4A85Q33769835-1D084C0C-B5FC-4989-8146-6AC1D7D9B301Q33917524-F0678BA6-4A86-42F6-BC47-98DC551C51E8Q35077659-8B45310F-76F7-4C3F-B865-CB8F2967A0F5Q35322855-75500C38-80A6-4CA4-9B04-9CCACDC61C80Q36609881-34D4140A-06AD-4C3C-9B18-142763DD794CQ37672959-B175AEFB-2EDA-40F2-A4FD-3820C3D8F77AQ38869295-CFB81639-9EFC-4111-8A5A-C448E372BB28Q41473512-8DA3F4DB-267E-46BD-9233-E6520CEE5D45Q47948941-3F791B35-AF38-4678-A9ED-549A1816B215Q55506772-C5FB18C8-4704-4202-B05C-B25602A0774D
P2860
Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Diverse responses to vascular ...... giography, and histopathology.
@ast
Diverse responses to vascular ...... giography, and histopathology.
@en
type
label
Diverse responses to vascular ...... giography, and histopathology.
@ast
Diverse responses to vascular ...... giography, and histopathology.
@en
prefLabel
Diverse responses to vascular ...... giography, and histopathology.
@ast
Diverse responses to vascular ...... giography, and histopathology.
@en
P2093
P2860
P356
P1476
Diverse responses to vascular ...... giography, and histopathology.
@en
P2093
Alfons Verbruggen
Jian Zhang
Marlein Miranda Cona
Raymond Oyen
Yicheng Ni
Yuanbo Feng
P2860
P356
10.1593/TLO.12367
P577
2013-02-01T00:00:00Z